Prostate: MEVPRO-1
Trial ID
06551324
Trial Sponsor
Pfizer
Prostate: MEVPRO-1 (C2321014)
A Phase 3, Randomized, Open-Label Study of PF-06821497 (Mevrometostat) in Combination with Enzalutamide Compared with Enzalutamide or Docetaxel in Participants with Metastatic Castration Resistant Prostate Cancer Previously Treated with Abiraterone Acetate